{"altmetric_id":12952452,"counts":{"readers":{"mendeley":14,"citeulike":0,"connotea":0},"total":{"posts_count":1},"news":{"unique_users_count":1,"unique_users":["the_conversation"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa60b3cf058f610006a66","authors":["Higgins SC","Pilkington GJ"],"first_seen_on":"2016-10-24T15:47:33+00:00","handles":[],"isbns":[],"issns":["0250-7005"],"issue":"2","journal":"Anticancer Research: International Journal of Cancer Research and Treatment","last_mentioned_on":1477321361,"links":["https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20332444"],"pmid":"20332444","pubdate":"2010-02-15T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["neoplasms"],"title":"The in vitro effects of tricyclic drugs and dexamethasone on cellular respiration of malignant glioma.","type":"article","volume":"30","mendeley_url":"http:\/\/www.mendeley.com\/research\/vitro-effects-tricyclic-drugs-dexamethasone-cellular-respiration-malignant-glioma"},"altmetric_score":{"score":8,"score_history":{"1y":8,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":8},"context_for_score":{"all":{"total_number_of_other_articles":7588328,"mean":6.5418890751503,"rank":938486,"this_scored_higher_than_pct":87,"this_scored_higher_than":6629121,"rank_type":"exact","sample_size":7588328,"percentile":87},"similar_age_3m":{"total_number_of_other_articles":235310,"mean":12.652860587568,"rank":45265,"this_scored_higher_than_pct":80,"this_scored_higher_than":189539,"rank_type":"exact","sample_size":235310,"percentile":80},"this_journal":{"total_number_of_other_articles":1661,"mean":3.6426120481928,"rank":88,"this_scored_higher_than_pct":94,"this_scored_higher_than":1568,"rank_type":"exact","sample_size":1661,"percentile":94},"similar_age_this_journal_3m":{"total_number_of_other_articles":42,"mean":14.556829268293,"rank":4,"this_scored_higher_than_pct":90,"this_scored_higher_than":38,"rank_type":"exact","sample_size":42,"percentile":90}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor > Associate Professor":1,"Student  > Doctoral Student":1,"Researcher":3,"Student  > Ph. D. Student":4,"Student  > Master":1,"Student  > Bachelor":3,"Lecturer":1},"by_discipline":{"Medicine and Dentistry":3,"Chemistry":1,"Agricultural and Biological Sciences":8,"Biochemistry, Genetics and Molecular Biology":1,"Unspecified":1}}}},"posts":{"news":[{"title":"How an old antidepressant could provide the next brain cancer breakthrough","url":"http:\/\/ct.moreover.com\/?a=28385845099&p=1pl&v=1&x=Dwl8KYPkcC_uabiD0815HQ","license":"public","citation_ids":[4524603,5351049,12952451,12952452],"posted_on":"2016-10-24T15:02:41+00:00","summary":"In 1998, I received an intriguing handwritten note. It came from David Wilkie, emeritus professor at University College London, and asked if I thought the antidepressant drug clomipramine could affect brain tumours.","author":{"name":"The Conversation","url":"http:\/\/theconversation.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/071\/normal\/the_conversation.png?1369846953"}}]}}